Timeline

Isabelle Rosinski-Chupin

page

15 May 2024

publication

An antiplasmid system drives antibiotic resistance gene integration in carbapenemase-producing Escherichia coli lineages.

25 Apr 2023

publication

A Novel CovS Variant Harbored by a Colonization Strain Reduces Streptococcus pyogenes Virulence.

11 Jan 2022

publication

Specificities and Commonalities of Carbapenemase-Producing Escherichia coli Isolated in France from 2012 to 2015.

01 Sep 2021

publication

The CovR regulatory network drives the evolution of Group B Streptococcus virulence.

01 Jun 2021

publication

Evolution of VIM-1-Producing Klebsiella pneumoniae Isolates from a Hospital Outbreak Reveals the Genetic Bases of the Loss of the Urease-Positive Identification Character.

27 Oct 2020

publication

Diversity of mucoid to non-mucoid switch among carbapenemase-producing Klebsiella pneumoniae.

20 Jan 2020

publication

Stepwise evolution and convergent recombination underlie the global dissemination of carbapenemase-producing Escherichia coli.

22 Mar 2019

publication

Conserved and specific features of Streptococcus pyogenes and Streptococcus agalactiae transcriptional landscapes.

15 Oct 2018

publication

A 4.5-Year Within-Patient Evolution of a Colistin-Resistant Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Sequence Type 258.

01 Jan 2018

publication

Transcriptional Landscape of a blaKPC-2 Plasmid and Response to Imipenem Exposure in Escherichia coli TOP10.

05 Sep 2017

publication

Parallel Evolution of Group B Streptococcus Hypervirulent Clonal Complex 17 Unveils New Pathoadaptive Mutations.

29 Aug 2016

team

Ecology and Evolution of Antibiotics Resistance

17 Aug 2015

publication

Whole-Genome Comparison Uncovers Genomic Mutations between Group B Streptococci Sampled from Infected Newborns and Their Mothers

30 May 2015

publication

Single nucleotide resolution RNA-seq uncovers new regulatory mechanisms in the opportunistic pathogen Streptococcus agalactiae.

04 Aug 2014

publication

Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.

04 Aug 2014

publication

Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.

01 Sep 2012

publication

A little guide for advanced search:

Timeline

An antiplasmid system drives antibiotic resistance gene integration in carbapenemase-producing Escherichia coli lineages.

A Novel CovS Variant Harbored by a Colonization Strain Reduces Streptococcus pyogenes Virulence.

Specificities and Commonalities of Carbapenemase-Producing Escherichia coli Isolated in France from 2012 to 2015.

The CovR regulatory network drives the evolution of Group B Streptococcus virulence.

Evolution of VIM-1-Producing Klebsiella pneumoniae Isolates from a Hospital Outbreak Reveals the Genetic Bases of the Loss of the Urease-Positive Identification Character.

Diversity of mucoid to non-mucoid switch among carbapenemase-producing Klebsiella pneumoniae.

Stepwise evolution and convergent recombination underlie the global dissemination of carbapenemase-producing Escherichia coli.

Conserved and specific features of Streptococcus pyogenes and Streptococcus agalactiae transcriptional landscapes.

A 4.5-Year Within-Patient Evolution of a Colistin-Resistant Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Sequence Type 258.

Transcriptional Landscape of a blaKPC-2 Plasmid and Response to Imipenem Exposure in Escherichia coli TOP10.

Parallel Evolution of Group B Streptococcus Hypervirulent Clonal Complex 17 Unveils New Pathoadaptive Mutations.

Ecology and Evolution of Antibiotics Resistance

Whole-Genome Comparison Uncovers Genomic Mutations between Group B Streptococci Sampled from Infected Newborns and Their Mothers

Single nucleotide resolution RNA-seq uncovers new regulatory mechanisms in the opportunistic pathogen Streptococcus agalactiae.

Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.

Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.

The highly dynamic CRISPR1 system of Streptococcus agalactiae controls the diversity of its mobilome.